Heather Kiessling Sells 80,000 Shares of ASP Isotopes (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 80,000 shares of ASP Isotopes stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $5.80, for a total transaction of $464,000.00. Following the sale, the chief financial officer owned 732,500 shares in the company, valued at approximately $4,248,500. This represents a 9.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

ASP Isotopes Stock Down 5.1%

ASP Isotopes stock opened at $5.42 on Wednesday. ASP Isotopes Inc. has a 52 week low of $3.65 and a 52 week high of $14.49. The stock has a market cap of $600.75 million, a price-to-earnings ratio of -4.17 and a beta of 3.41. The company’s 50-day moving average price is $7.22 and its two-hundred day moving average price is $8.49. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings results on Wednesday, November 19th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%.The company had revenue of $4.89 million during the quarter, compared to analyst estimates of $2.25 million. On average, analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ASPI shares. Canaccord Genuity Group reiterated a “buy” rating and set a $11.00 price target on shares of ASP Isotopes in a research report on Monday, November 24th. Cantor Fitzgerald initiated coverage on ASP Isotopes in a report on Thursday, December 4th. They set an “overweight” rating and a $13.00 target price on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday. Finally, Loop Capital set a $15.00 price objective on shares of ASP Isotopes in a research note on Monday, October 27th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $13.00.

Institutional Investors Weigh In On ASP Isotopes

Several hedge funds have recently modified their holdings of the stock. Exchange Traded Concepts LLC purchased a new stake in shares of ASP Isotopes during the second quarter worth $9,593,000. AlphaQuest LLC acquired a new stake in ASP Isotopes in the second quarter valued at approximately $256,000. Rovida Advisors Inc. bought a new stake in ASP Isotopes in the second quarter worth approximately $16,148,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of ASP Isotopes during the 2nd quarter worth $331,000. Finally, Harbour Capital Advisors LLC acquired a new position in shares of ASP Isotopes during the 2nd quarter worth $232,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.